Skip to main content

Table 2 Haemosporidian lineage occurrence and co-occurrence with Wolbachia and insecticide resistance in mosquitoes collected in Southern France in 2006

From: Dynamics of prevalence and diversity of avian malaria infections in wild Culex pipiens mosquitoes: the effects of Wolbachia, filarial nematodes and insecticide resistance

 

Haemosporidians lineages

Total number (proportion)

Sampling time

Sampling location

w Pip groups

Insecticide resistance

 

SUS

TC

MEJ

MDV

II

III

S

E

A

AE

Plasmodium

SGS1

44* (3.81)

April to October

8

22

5

9

27

17

6

32

 

6

DELURB4

21 (1.82)

April to October

1

9

7

4

9

12

5

14

1

1

DELURB5

10* (0.87)

May to August, October

 

4

3

3

2

8

1

7

 

1

PADOM01

7 (0.61)

July, August

1

2

4

 

2

5

1

4

 

2

GRW06

3 (0.26)

August, September

 

2

 

1

1

2

 

2

 

1

SYAT05

3 (0.26)

April, June

 

2

1

  

3

 

3

  

COLL1

1 (0.09)

May

  

1

 

1

  

1

  

CXPIPS1

1 (0.09)

August

 

1

  

1

  

1

  

CXPIPS2

1 (0.09)

August

1

   

1

    

1

GRW11

1 (0.09)

September

 

1

  

1

  

1

  

LINN1

1 (0.09)

September

 

1

   

1

1

   

PADOM01 like

1 (0.09)

June

 

1

  

1

  

1

  

SGS1 like

1 (0.09)

June

 

1

   

1

 

1

  

Haemoproteus

CXPIPS3

2 (0.17)

May

  

1

1

1

1

 

1

  

GAGLA03

1 (0.09)

August

1

   

1

  

1

  

Total number of mosquitoes tested

96 sequenced

149

543

299

165

89

102

26

138

1

23

  1. A total of 1156 mosquitoes were sampled for this study. Lineages are given for each haemosporidian genus: Plasmodium and Haemoproteus. Asterisks represent multiple infections (two mosquitoes were infected by both SGS1 and DELURB5). The number of infected mosquitoes is given for each sampling location (SUS, Sussargues; TC, Tour Carbonnière; MEJ, Méjanes; MDV, Marais du Vigueirat), Wolbachia group, and insecticide resistance status (S, fully susceptible; E, resistant through carboxylesterase overproduction; A, resistant through acetylcholinesterase modification; AE, resistant through both acetylcholinesterase modification and esterase overproduction).